In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Hiroki KatoInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0003-0838-6772 Xuhao HuangInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0003-0342-1292 Erina HilmayantiDepartment of Chemistry, Graduate School of Science, The University of Osaka, Toyonaka 560-0043, Osaka, Japan.
Yuichiro KadonagaInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.
Kazuhiro OoeInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0002-8560-027X Masashi MurakamiInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0001-7936-2263 Kazuya KabayamaInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.
Kazuko Kaneda-NakashimaInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0001-6657-5059 Atsushi ToyoshimaInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.
Xiaojie YinNishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Saitama, Japan.
Koichi FukaseInstitute for Radiation Sciences, The University of Osaka, 2-4, Yamadaoka, Suita 565-0871, Osaka, Japan.
Funding
Japan Agency for Medical Research and Development 25ym0126144h0002Japan Agency for Medical Research and Development JP23ym0126809Japan Science and Technology Agency JPMJER2102Japan Society for the Promotion of Science 20H05675Japan Society for the Promotion of Science 22H04924Japan Society for the Promotion of Science 22J10766Japan Society for the Promotion of Science 23H02765Japan Society for the Promotion of Science 24H00804Japan Society for the Promotion of Science 25H00006
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
alpha emittersastatine-211cancer therapygold nanoparticlesradiolabeling
What Socratic holds
Textmetadata
Read underepoch 390